601 related articles for article (PubMed ID: 29923637)
1. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
Andrilla CHA; Moore TE; Patterson DG; Larson EH
J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
[TBL] [Abstract][Full Text] [Related]
2. Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder.
Andrilla CHA; Patterson DG
J Rural Health; 2022 Jan; 38(1):87-92. PubMed ID: 33733547
[TBL] [Abstract][Full Text] [Related]
3. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
Andrilla CHA; Jones KC; Patterson DG
J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
[TBL] [Abstract][Full Text] [Related]
4. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
Barnett ML; Lee D; Frank RG
Health Aff (Millwood); 2019 Dec; 38(12):2048-2056. PubMed ID: 31794302
[TBL] [Abstract][Full Text] [Related]
5. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.
Ghertner R
Drug Alcohol Depend; 2019 Nov; 204():107527. PubMed ID: 31525570
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply.
Auty SG; Stein MD; Walley AY; Drainoni ML
J Subst Abuse Treat; 2020 Aug; 115():108032. PubMed ID: 32600629
[TBL] [Abstract][Full Text] [Related]
7. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
Andrilla CHA; Moore TE; Patterson DG
J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
[TBL] [Abstract][Full Text] [Related]
9. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
[TBL] [Abstract][Full Text] [Related]
10. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
Andrilla CHA; Coulthard C; Patterson DG
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
[TBL] [Abstract][Full Text] [Related]
11. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.
Andraka-Christou B; Page C; Schoebel V; Buche J; Haffajee RL
Addict Sci Clin Pract; 2022 Aug; 17(1):43. PubMed ID: 35945636
[TBL] [Abstract][Full Text] [Related]
13. Expanding Opioid Use Disorder Treatment in Priority Areas: The Role of Certified Nurse-Midwives.
Kane C; Topmiller M
J Midwifery Womens Health; 2022 May; 67(3):314-320. PubMed ID: 35506768
[TBL] [Abstract][Full Text] [Related]
14. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
Grove LR; Rao N; Domino ME
Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
[TBL] [Abstract][Full Text] [Related]
15. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
[TBL] [Abstract][Full Text] [Related]
16. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
Knudsen HK
J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Distribution, and Characteristics Associated With Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States.
Fujita AW; Loughry N; Moore DE; Carter AE; Hussen SA; Cooper H; Colasanti JA; Sheth AN
Clin Infect Dis; 2023 Apr; 76(7):1197-1204. PubMed ID: 36419250
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
20. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
Andrilla CHA; Coulthard C; Larson EH
Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]